article Open AccessTop 1% cited
Modeling Alzheimer’s Disease with iPSCs Reveals Stress Phenotypes Associated with Intracellular Aβ and Differential Drug Responsiveness
Cell stem cell · 2013 · Vol. 12(4) · pp. 487–496
Takayuki Kondo(Kyoto University)Masashi Asai(Japan Science and Technology Agency)Kayoko Tsukita(Kyoto University)Yumiko Kutoku(Kawasaki Medical School)Yutaka Ohsawa(Kawasaki Medical School)Yoshihide Sunada(Kawasaki Medical School)Keiko Imamura(Kyoto University)Naohiro Egawa(Kyoto University)Naoki Yahata(Kyoto University)Keisuke Okita(Kyoto University)Kazutoshi Takahashi(Kyoto University)Isao Asaka(Kyoto University)Takashi Aoi(Kyoto University)Akira Watanabe(Kyoto University)Kaori Watanabe(Japan Science and Technology Agency)Chie Kadoya(Japan Science and Technology Agency)Rie Nakano(Japan Science and Technology Agency)Dai Watanabe(Kyoto University)Kei Maruyama(Saitama Medical University)Osamu Hori(Kanazawa University)Satoshi Hibino(Fukuyama University)Tominari Choshi(Fukuyama University)Tatsutoshi Nakahata(Kyoto University)Hiroyuki Hioki(Kyoto University)Takeshi Kaneko(Kyoto University)Motoko Naitoh(Kyoto University)Katsuhiro Yoshikawa(Kyoto University)Satoko Yamawaki(Kyoto University)Shigehiko Suzuki(Kyoto University)Ryuji Hata(Ehime University)Shu-ichi Ueno(Ehime University)Tsuneyoshi Seki(Kobe University)Kazuhiro Kobayashi(Kobe University)Tatsushi Toda(Kobe University)Kazuma Murakami(Kyoto University)Kazuhiro Irie(Kyoto University)William L. Klein(Northwestern University)Hiroshi Mori(Osaka City University)Takashi Asada(University of Tsukuba)Ryōsuke Takahashi(Kyoto University)Nobuhisa Iwata✉(Japan Science and Technology Agency)Shinya Yamanaka(Kyoto University)Haruhisa Inoue✉(Kyoto University)
Alzheimer's disease research and treatmentsComputational Drug Discovery MethodsCholinesterase and Neurodegenerative DiseasesBiologyPhenotypeDiseaseIntracellularDrugInduced pluripotent stem cellDrug discoveryNeuroscienceCell biologyBioinformatics
MeSH terms
Alzheimer DiseaseCell DifferentiationCerebral CortexDocosahexaenoic AcidsHumansModels, BiologicalNeuronsPhenotypeAmyloid beta-PeptidesOxidative StressProtein Structure, QuaternaryIntracellular SpaceMutant ProteinsInduced Pluripotent Stem Cells
Citations
744
FWCI
42.46
field-weighted impact
References
30
Percentile
100%
vs. same field & year
Citations per year
Cited by
Alzheimer’s disease: experimental models and reality
Acta Neuropathologica · 2016 · 787 citations
Induced pluripotent stem cell technology: a decade of progress
Nature Reviews Drug Discovery · 2016 · 1,499 citations
References
Soluble protein oligomers in neurodegeneration: lessons from the Alzheimer's amyloid β-peptide
Nature Reviews Molecular Cell Biology · 2007 · 4,679 citations
A more efficient method to generate integration-free human iPS cells
Nature Methods · 2011 · 2,071 citations
Neurodegenerative diseases and oxidative stress
Nature Reviews Drug Discovery · 2004 · 3,623 citations
ω-3 Fatty Acid Treatment in 174 Patients With Mild to Moderate Alzheimer Disease: OmegAD Study
Archives of Neurology · 2006 · 741 citations
Amyloid-β protein dimers isolated directly from Alzheimer's brains impair synaptic plasticity and memory
Nature Medicine · 2008 · 3,621 citations
Modeling familial Alzheimer's disease with induced pluripotent stem cells
Human Molecular Genetics · 2011 · 600 citations
Citation Network
How this paper connects to the literature. Drag to explore, click any node to open that paper.
